Nestlé has announced it will invest more than €25m in the expansion of its R&D centre at its Wyeth Nutritionals facility at Askeaton in Co Limerick. The Wyeth facility produces a range of premium powdered milk-based products for infants, young children and mothers for export to world markets.
The investment will expand the existing R&D centre at Askeaton, which will focus on developing product innovations for Wyeth’s infant formula and maternal nutrition business. The facility expansion is expected to open in late 2017.
Critical
ADVERTISEMENT
Director of Enterprise Ireland’s food division Michael Cantwell described Nestlé’s investment in its R&D facility in Askeaton as being of “critical strategic importance”.
“This is a strategically important investment for Ireland and is a huge vote of confidence in the future of the Irish dairy industry and the research connectedness in Ireland,” added Cantwell.
Nestlé’s chief technology officer Stefan Catsicas said that the Askeaton investment would position Nestlé at the fore of infant and maternal nutritional product development.
“[The investment] will incorporate state of the art laboratory facilities as well as a full pilot-scale manufacturing line to facilitate development and testing of new products from initial concept through to finished product development,” said Catsicas.
Register for free to read this story and our free stories.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Nestlé has announced it will invest more than €25m in the expansion of its R&D centre at its Wyeth Nutritionals facility at Askeaton in Co Limerick. The Wyeth facility produces a range of premium powdered milk-based products for infants, young children and mothers for export to world markets.
The investment will expand the existing R&D centre at Askeaton, which will focus on developing product innovations for Wyeth’s infant formula and maternal nutrition business. The facility expansion is expected to open in late 2017.
Critical
Director of Enterprise Ireland’s food division Michael Cantwell described Nestlé’s investment in its R&D facility in Askeaton as being of “critical strategic importance”.
“This is a strategically important investment for Ireland and is a huge vote of confidence in the future of the Irish dairy industry and the research connectedness in Ireland,” added Cantwell.
Nestlé’s chief technology officer Stefan Catsicas said that the Askeaton investment would position Nestlé at the fore of infant and maternal nutritional product development.
“[The investment] will incorporate state of the art laboratory facilities as well as a full pilot-scale manufacturing line to facilitate development and testing of new products from initial concept through to finished product development,” said Catsicas.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS